delay in diagnosis of motor neuron disease. a tertiary care experience by Brohi, Hazim et al.
Pakistan Journal of
Neurological Sciences (PJNS)
Volume 9 | Issue 1 Article 4
1-2014
delay in diagnosis of motor neuron disease. a
tertiary care experience
Hazim Brohi
Liaquat National Hospital, Karachi, Pakistan
Naveed Uddin Ahmed
Liaquat National Hospital, Karachi, Pakistan
Rajesh Khatri
Liaquat National Hospital, Karachi, Pakistan.
Ishaq Asghar
Liaquat National Hospital, Karachi, Pakistan.
Follow this and additional works at: http://ecommons.aku.edu/pjns
Part of the Neurology Commons
Recommended Citation
Brohi, Hazim; Ahmed, Naveed Uddin; Khatri, Rajesh; and Asghar, Ishaq (2014) "delay in diagnosis of motor neuron disease. a tertiary
care experience," Pakistan Journal of Neurological Sciences (PJNS): Vol. 9: Iss. 1, Article 4.
Available at: http://ecommons.aku.edu/pjns/vol9/iss1/4
O R I G I N A L  A R T I C L E
DELAY IN DIAGNOSIS OF MOTOR NEURON DISEASE.
A TERTIARY CARE EXPERIENCE
Hazim Brohi1, Naveed Uddin Ahmed2, Rajesh Khatri3, Ishaq Asghar4
1 Associate Professor Neurology Department LNH Karachi
2 Assistant Professor Neurology Department LNH Karachi
3 Resident Neurology Department LNH Karachi
4 Intern LNH Karachi
ABSTRACT
Motor Neuron Disease is a progressive neurological disorder with poor prognosis. Inability to correctly recognize the 
disease, leads to undue agony and diagnostic dilemma. Studies have been done to look at the average duration taken 
to diagnose the disease from the onset of symptoms. The literature shows that latency from symptom onset to diagno-
sis   range from 10.6–17.5 months. No such study has been conducted in our region. We reviewed 62 patients referred 
to the neurophysiology lab from year 2009 to 2013 with quarry of MND. Only 40 patients were identified to fulfill the 
El Escorial criteria for MND. The median time of diagnosis from onset of symptoms was one year. This is almost similar 
to that of world literature. We conclude that in spite of paucity of heath service and high rate of illiteracy the timeliness 
of diagnosis was consistent with the rest of the world.
INTRODUCTION
Motor Neuron Disease (MND) is a progressive neurodegenerative disease that usually occurs in the fifth to sixth decades. 
The duration of survival is short, with an average life expectancy of less than 3 years after diagnosis1. Recent few studies 
have shown that the incidence and mortality rates of ALS have increased over the past several decades, possibly owing to 
ageing of the population2-3. Timely diagnosis is an essential component of high quality health care; particularly confirm a 
diagnosis as devastating as MND. Early diagnosis of MND is very important as significant psychological stress accompanies 
the period awaiting a diagnosis4. A study by Johnston et al reported that the majority of MND patients described positive 
attitude when ‘labelled’ for their condition and that the earlier diagnosis allows these patients to have more time to make 
personal and financial adjustments and make plans for the future, including modifications in  their homes to cope with 
impending disability and co formulating working plan5. The average latency from symptom onset to diagnosis in MND is 
about 14 months, about one third of expected survival. Occasionally, survival following diagnosis may be less than six 
months so a diagnosis is usually required before care can be organized6. According to the data from Ireland Motor Neuron 
disease the duration of diagnosis of MND from the onset was 15.6 months4. Our literature search revealed no such study 
from our region. No details are available regarding time taken for the diagnosis of this devastating disease.
METHODS
As NCS and EMG is the diagnostic test in spite of clinical suspicion, we assumed that the final label can only be given 
once the test has been done. So the time between the onset of symptoms and diagnosis will be” the time the patient 
becomes significantly symptomatic to seek medical help to the time he/she is labelled as suffering from MND and 
that’s when his/her electrophysiological study is done. This was a retrospective study. We reviewed the charts of all 
patients who came to neurophysiology laboratory at Liquat National Hospital with suspicion of MND from year 2009 
to year 2013. The charts used for recording the data were reviewed for details of the patient like onset of symptoms, 
age, gender and the EMG details. The data was then entered on a self designed questionnaire. Patients fulfilling EL 
Escorial criteria were considered as suffering from MND. SPSS version 18 was used for analysis of the results. 
RESULTS
Total of 62 patients were referred to rule out motor neuron disease. Eight patients did not show anterior horn cell 
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involvement. Out of remaining Fifty four patients 40 patients i.e. 64% fulfilled the El Escorial criteria for MND, 13 
patients i.e. 21% had suggestion of anterior horn cell involvement but did not have 3 areas involved as per El Escorial 
criteria. The median time of diagnosis from onset of symptoms was 1 year. 67 % patients had tongue involvement 
and 82 % had spine involvement at time of diagnosis. Limb involvement was almost 95%.
DISCUSSION
Our literature search failed to show any study regarding time lapsed between onset of symptoms and diagnosis of MND 
from our region. As most patients with ALS die of respiratory failure, usually within 3 to 5 years from the onset of symptoms, 
the time is limited for patient.  Even in well developed countries the time to diagnosis is prolonged. According to a study 
from Ireland the survival time from diagnosis to death was 16.4 months (5) and the diagnostic time was 15.6 months. As 
no such information was available from third world countries, the diagnostic delay may be very long. We conducted this 
study to see the time to diagnosis in our setup.  Surprisingly the median time of diagnosis was one year. A detailed review 
of the data showed a diverse range of time ranging from 1 month to 4 years. We believe the short duration from onset may 
not be true representative as certain patients are illiterate and may not have noticed the disease until late or due to lack of 
proper diagnosis, the patient may have been roaming around till it was too late. However the median time was one year, 
which seems to be in accordance with literature quoted from the western countries. Another important observation was the 
fact that around 21 % patients were not labelled as motor neuron disease as only El Escorial criteria was used for the 
diagnostic purposes. Recently Awagi Shiama criteria is being used which is less stringent and more patients may have quali-
fied for diagnosis of MND using these criteria7. The median time, when including all patients with anterior horn cell was 9 
months. According to the study conducted in Ireland, which is a community based study, the correct diagnosis was made 
in 95 % patients by neurologist compared to 5 % patients seen by general physicians4. Thus properly referred patients will 
have less diagnostic delay. We conclude that greater public awareness especially among health care professionals such as 
primary care physicians and readily availability of neurologists may save patient from the agony of diagnostic delay.
Number of patients Percent
Patient fulfilling
criteria
40 64.5
Not fulfilling
Criteria
13 21.0
Patient with other
Diagnosis
9 14.5
Total number of patients 62 100
Chart 1: Numbers of patients fulfilling El Escorial criteria 
Chart 2: Median time from onset to diagnosis
Fulfill El Escorial Criteria 1 Year
All Anterior horn cell 9 Months
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Chart 3: Details of time duration
Table 4: Details of EMG findings (denervation, high broad MUAP)
Duration No of  Patients Percent
1 Months 1 2.5
2 Months 3 7.5
3 Months 5 12.5
4 Months 1 2.5
5 Months 3 7.5
6 Months 3 7.5
8 Mont hs 1 2.5
9 Months 2 5.0
1 Year 6 15.0
1.5 Year 3 7.5
2 Years 2 5.0
2.5 Years 1 2.5
3 Years 3 7.5
4 Years 1 2.5
Not mention 5 12.5
Total 40 100
Site involvement Frequency Percent
tongue 27 67.5
spine 33 82.5
Right upper limb 49 90.7
Left upper limb 45 83
Right lower limb 47 87
Left lower limb 47 87
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